EXTRANCHECK: POST-SHIPMENT VERIFICATION: INDIAN

UNCLAS NEW DELHI 002477 SIPDIS USDOC FOR 532/OEA/M. NICKSON-D/K.GAINS USDOC FOR 3131/USFCS/OIO/ANESA/KREISSL USDOC FOR 4530/MAC/ANESA/OSA ICE HQ FOR STRATEGIC INVESTIGATIONS STATE FOR EB/ESP E.O. 12958: N/A TAGS: BEXP ETRD ETTC IN SUBJECT: EXTRANCHECK: POST-SHIPMENT VERIFICATION: INDIAN IMMUNOLOGICALS LIMITED, HYDERABAD, INDIA REF: USDOC 05147 ¶1. Unauthorized disclosure of the information provided below is prohibited by Section 12(c) of the Export Administration Act. ¶2. On August 27, 2008, Export Control Officer (ECO) Paul Cushman and BIS FSN Shailendra Srivastava conducted a Post-Shipment Verification (PSV) at Indian Immunologicals Limited (IIL) in Hyderabad. ¶3. BIS requested a PSV at IIL, located at Rakshapuram, Post Gachibowli, Hyderabad. IIL was listed as the end-user for three PROSTAK Microfiltration Modules manufactured by Millipore Corporation of Burlington, Massachusetts. Export License: D379896. ECCN: 7A103. ¶4. ECO and FSN Srivastava met with Dr. G. Kamaraj, Manager- Production, Mr. B. Venugopal Rao, Manager-Production, Mr. Putikam Srinivas, Manager-Production and Mr. K. Sreekanth, Quality Systems, Human Biologicals Institute, IIL. Mr. Randhir Jaiswal, Deputy Secretary, Ministry of External Affairs, arranged and was present at the meeting which was held in the facility's conference room. ¶5. IIL representatives were not familiar with BIS regulations and this was the first visit by BIS officials to their facility. Rao provided the following documents relating to this transaction: IIL Purchase Order, Millipore Invoice and IIL End-Use Statement. ¶6. Rao stated that the filters will be incorporated in an automated vaccine manufacturing system when the current filters wear out. ¶7. After the meeting, the BIS team was given a tour of the facility. The ECO physically verified the filters' part number as SK2P242E9 and lot number C7CN39026. The filters are secured in a store room and only authorized personnel have the access to them. A roving security force is on duty at the facility 24/365. ¶8. Established in 1983, IIL is a subsidiary of GOI's National Dairy Development Board. This facility manufactures a variety of vaccines including rabies, diphtheria, pertussis, tetanus, hepatitis A, hepatitis B, and measles. In addition, it operates one of the largest veterinary vaccine plants in the world and has been awarded the ISO 9002 quality control certificate by the World Health Organization. IIL sells its vaccines through franchisees, ABHAY Clinics, and Jivan Vaccine Centers throughout India. ¶9. Recommendation: At the time of this visit, Indian Immunologicals Limited appeared to be a reliable recipient of this controlled technology. The items on check were physically verified and it appears they will be used in a manner consistent with the Export Administration Regulations. MULFORD